{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:23:05Z","timestamp":1761060185897},"reference-count":25,"publisher":"Impact Journals, LLC","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,9,27]]},"DOI":"10.18632\/oncotarget.11494","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T22:26:22Z","timestamp":1471904782000},"page":"63758-63766","source":"Crossref","is-referenced-by-count":6,"title":["Gene status and clinicopathologic characteristics of lung adenocarcinomas with mediastinal lymph node metastasis"],"prefix":"10.18632","volume":"7","author":[{"given":"Shumeng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1101\/gr.145144.112","article-title":"The transcriptional landscape and mutational profile of lung adenocarcinoma","volume":"22","author":"Kang","year":"2012","journal-title":"Genome Res"},{"key":"2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00432-014-1584-8","article-title":"Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status","volume":"140","author":"Mu","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/cas.12275","article-title":"RET fusion gene: translation to personalized lung cancer therapy","volume":"104","author":"Goto","year":"2013","journal-title":"Cancer Sci"},{"key":"4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2014.02.007","article-title":"ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features","volume":"84","author":"Sun","year":"2014","journal-title":"Lung Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ejcts.2006.08.008","article-title":"ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer","volume":"30","author":"Weder","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.resinv.2012.08.007","article-title":"Prognostic factors before and after recurrence of resected non-small cell lung cancer","volume":"50","author":"Tanaka","year":"2012","journal-title":"Respir Investig"},{"key":"7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/JTO.0000000000000405","article-title":"Molecularly targeted therapies in non-small-cell lung cancer annual update 2014","volume":"10","author":"Rudin","year":"2015","journal-title":"J Thorac Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1158\/1078-0432.CCR-15-0354","article-title":"ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer","volume":"21","author":"Vokes","year":"2015","journal-title":"Clin Cancer Res"},{"key":"9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1749-8090-6-144","article-title":"Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage III-N2 non-small cell lung cancer","volume":"6","author":"Tanaka","year":"2011","journal-title":"J Cardiothorac Surg"},{"key":"10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.lungcan.2009.03.004","article-title":"Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis","volume":"66","author":"Mitsudomi","year":"2009","journal-title":"Lung Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1038\/srep07268","article-title":"A large-scale cross-sectional study of ALK rearrangements and EGFR mutations in non-small-cell lung cancer in Chinese Han population","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci Rep"},{"key":"12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/JTO.0b013e31823c5c32","article-title":"Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma","volume":"7","author":"Molina","year":"2012","journal-title":"J Thorac Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF03262202","article-title":"Detection of anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer and related issues in ALK inhibitor therapy: a literature review","volume":"16","author":"Kerr","year":"2012","journal-title":"Mol Diagn Ther"},{"key":"14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.ejca.2014.02.001","article-title":"Prospective screening for ALK: clinical features and outcome according to ALK status","volume":"50","author":"Wislez","year":"2014","journal-title":"Eur J Cancer"},{"key":"15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2011.35.6345","article-title":"ROS1 rearrangements define a unique molecular class of lung cancers","volume":"30","author":"Chen","year":"2012","journal-title":"J Clin Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/his.12379","article-title":"ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases","volume":"65","author":"Weichert","year":"2014","journal-title":"Histopathology"},{"key":"17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1634\/theoncologist.2013-0095","article-title":"Novel targets in non-small cell lung cancer: ROS1 and RET fusions","volume":"18","author":"Shaw","year":"2013","journal-title":"Oncologist"},{"key":"18","first-page":"833","article-title":"The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations","volume":"9","author":"Chen","year":"2016","journal-title":"Onco Targets Ther"},{"key":"19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/aps.2013.164","article-title":"Correlation between serum CEA levels and EGFR mutations in Chinese nonsmokers with lung adenocarcinoma","volume":"35","author":"Han","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1245\/s10434-009-0808-7","article-title":"Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene","volume":"17","author":"Date","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1158\/1078-0432.CCR-13-0318","article-title":"ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer","volume":"19","author":"Ladanyi","year":"2013","journal-title":"Clin Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.lungcan.2012.04.012","article-title":"Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation","volume":"77","author":"Bang","year":"2012","journal-title":"Lung Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.lungcan.2013.04.009","article-title":"Coexistence of EGFR mutation and ALK translocation in NSCLC: literature review and case report of response to gefitinib","volume":"81","author":"Crino","year":"2013","journal-title":"Lung Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1158\/0008-5472.CAN-11-1340","article-title":"A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors","volume":"71","author":"Ercan","year":"2011","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mds626","article-title":"Oncogenic driver mutations in patients with non-small-cell lung cancer at various clinical stages","volume":"24","author":"He","year":"2013","journal-title":"Ann Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T20:11:20Z","timestamp":1692475880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":25,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2016,9,27]]}},"alternative-id":["11494","27563816"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11494","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]}}}